Browsing publications by Professor Chris Day

Newcastle AuthorsTitleYearFull text
Dr Dave Houghton
Professor Chris Day
Professor Michael Trenell
Gut microbiota and lifestyle interventions in NAFLD2016
Dr Timothy Hardy
Dr Mujdat Zeybel
Professor Chris Day
Dr Christian Dipper
Dr Steven Masson
et al.
Plasma DNA methylation: A potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease2016
Professor Chris Day
Dr Steven Masson
Professor Ann Daly
Professor Heather Cordell
Brief Report: Genetics of Alcoholic Cirrhosis-GenomALC Multinational Study2015
Sophie Cassidy
Dr Kate Hallsworth
Dr Christian Thoma
Dr Guy MacGowan
Dr Kieren Hollingsworth
et al.
Cardiac structure and function are altered in type 2 diabetes and Non-alcoholic fatty liver disease and associate with glycemic control2015
Anna Whitehead
Dr Gillian Patman
Professor Chris Day
Dr Dina Tiniakos
Dr Quentin Anstee
et al.
Effects of FXR agonist PX20606 on tumour formation in animal models of non-alcoholic fatty liver disease2015
Dr Stuart McPherson
Dr Timothy Hardy
Elsbeth Henderson
Professor Alastair Burt
Professor Chris Day
et al.
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management2015
Dr Dave Houghton
Dr Christian Thoma
Dr Kate Hallsworth
Dr Kieren Hollingsworth
Professor Chris Day
et al.
Exercise reduces liver fat, visceral fat and circulating triglycerides, but not circulating inflammatory markers in non-alcoholic steatohepatitis2015
Dr Quentin Anstee
Professor Ann Daly
Professor Chris Day
Genetics of Alcoholic Liver Disease2015
Dr Sarah Cassidy
Christian Thoma
Dr Kate Hallsworth
Dr Jehill Parikh
Dr Kieren Hollingsworth
et al.
High intensity intermittent training improves cardiac function and reduces liver fat in adults with Type 2 diabetes: an MRI/S study2015
Dr Stuart McPherson
Dr Timothy Hardy
Professor Alastair Burt
Professor Chris Day
Dr Quentin Anstee
et al.
High rate of false positives for advanced fibrosis when simple non-invasive fibrosis tests are used in older patients (>=65 years) with NAFLD2015
1234567891011121314151617181920...